
Fluoxetine (Prozac) as a Cause of QT Prolongation
Arch Intern Med. 2001;161:612.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
A variety of drugs have been identified as the cause of QT prolongation
and of risk of life-threatening ventricular arrhythmias. This association
is recognized for selected psychotherapeutic agents such as phenothiazines
and tricyclics. Antidepressant drugs that inhibit the central nervous system
neuronal uptake of serotonin have not been reported to have this effect on
the QT interval.1
Report of a Case
A 52-year-old man had preoperative risk assesment for elective prostate
surgery. Findings from physicial examination were normal, but those from an
electrocardiogram (ECG) showed broad-based T waves and a markedly prolonged
QTc interval of 0.56 second. An ECG recorded 3 months previously when treatment
with fluoxetine hydrochloride (Prozac) was started (20 mg for 2 weeks and
then 40 mg/d) for the management of depression showed a normal QTc interval
of 0.38 second. In addition, single-drug therapy with verapamil hydrochloride,
240 mg, had been started 3 years earlier for essential hypertension (stage
1) and . . . [Full Text of this Article] Comment
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Antenatal Use of Selective Serotonin-Reuptake Inhibitors and QT Interval Prolongation in Newborns
Dubnov-Raz et al.
Pediatrics 2008;122:e710-e715.
ABSTRACT
| FULL TEXT
Association of antipsychotic and antidepressant drugs with Q-T interval prolongation
Zemrak and Kenna
Am J Health Syst Pharm 2008;65:1029-1038.
ABSTRACT
| FULL TEXT
QTc Prolongation and Torsades de Pointes in an Elderly Woman Taking Fluoxetine
WILTING et al.
Am. J. Psychiatry 2006;163:325-325.
FULL TEXT
Prolonged QT interval in an infant of a fluoxetine treated mother
Dubnov et al.
Arch. Dis. Child. 2005;90:972-973.
ABSTRACT
| FULL TEXT
The Antidepressant Drug Fluoxetine Is an Inhibitor of Human Ether-A-Go-Go-Related Gene (HERG) Potassium Channels
Thomas et al.
J. Pharmacol. Exp. Ther. 2002;300:543-548.
ABSTRACT
| FULL TEXT
|